# Continuous vs. Intermittent Infusion Vancomycin

> **NCT05823116** · PHASE4 · COMPLETED · sponsor: **Aaron Cook** · enrollment: 37 (actual)

## Conditions studied

- Vancomycin

## Interventions

- **DRUG:** Vancomycin Continuous Infusion
- **DRUG:** Vancomycin Intermittent Infusion

## Key facts

- **NCT ID:** NCT05823116
- **Lead sponsor:** Aaron Cook
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-22
- **Primary completion:** 2025-06-15
- **Final completion:** 2025-06-15
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2025-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05823116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05823116, "Continuous vs. Intermittent Infusion Vancomycin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05823116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*